Simon Doehrmann

Title: Simon Doehrmann: Innovator in Viral Infection Treatment

Introduction

Simon Doehrmann is a notable inventor based in San Diego, California. He has made significant contributions to the field of viral infection treatment through his innovative research and development efforts. His work focuses on creating effective compositions and methods to combat viral infections, particularly influenza.

Latest Patents

Simon Doehrmann holds a patent for "Compositions and methods for the treatment of viral infections." This patent includes conjugates containing inhibitors of viral neuraminidase, such as zanamivir and peramivir, linked to various proteins and peptides. These conjugates are designed to be used in the treatment of viral infections, specifically targeting influenza.

Career Highlights

Doehrmann is currently associated with Cidara Therapeutics, Inc., where he continues to advance his research in antiviral therapies. His work has been instrumental in developing new treatment options that can potentially improve patient outcomes in viral infections.

Collaborations

Simon collaborates with esteemed colleagues, including James M. Balkovec and Daniel C. Bensen, to further enhance the impact of his research. Their combined expertise contributes to the innovative approaches being explored at Cidara Therapeutics.

Conclusion

Simon Doehrmann's contributions to the treatment of viral infections highlight his role as a key innovator in the field. His patent and ongoing research efforts demonstrate a commitment to improving healthcare solutions for viral diseases.